益盛药业
(002566)
| 流通市值：16.15亿 | | | 总市值：23.03亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 338,483,583.1 | 178,610,348.46 | 640,173,748.36 | 476,195,233.12 |
| 营业收入 | 338,483,583.1 | 178,610,348.46 | 640,173,748.36 | 476,195,233.12 |
| 二、营业总成本 | 327,911,771.13 | 171,901,860.11 | 627,180,152.74 | 461,908,412.48 |
| 营业成本 | 84,022,853.22 | 44,719,779.22 | 166,500,857.65 | 118,512,783.81 |
| 税金及附加 | 8,229,002.51 | 4,270,344.69 | 16,121,256.6 | 12,117,786.86 |
| 销售费用 | 168,302,268.57 | 88,787,488.31 | 317,442,210.13 | 237,468,154.46 |
| 管理费用 | 53,080,560.41 | 26,509,146.99 | 99,704,678.88 | 72,647,166.77 |
| 研发费用 | 8,549,943.58 | 4,540,392.11 | 15,135,258.28 | 11,554,503.24 |
| 财务费用 | 5,727,142.84 | 3,074,708.79 | 12,275,891.2 | 9,608,017.34 |
| 其中:利息费用 | 5,819,260.3 | 3,088,133.7 | 12,621,970.76 | 9,922,335.84 |
| 其中:利息收入 | 207,515.26 | 52,947.81 | 462,327.36 | 419,692.74 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,542,771.84 | 2,998,088.06 | -3,824,213.82 | -5,629,868.61 |
| 加:投资收益 | 11,959,776.69 | 3,091,103.68 | 13,350,997.91 | 11,565,434.04 |
| 资产处置收益 | - | 67,023.08 | 400,967.64 | 282,362.32 |
| 资产减值损失(新) | -497,503.72 | - | -2,443,310.34 | - |
| 信用减值损失(新) | -3,646,353.9 | -1,983,029.61 | -2,731,208.27 | -1,834,815.19 |
| 其他收益 | 11,360,032.32 | 8,022,638.91 | 13,568,224.44 | 10,134,877.71 |
| 四、营业利润 | 32,290,535.2 | 18,904,312.47 | 31,315,053.18 | 28,804,810.91 |
| 加:营业外收入 | 9,399.71 | - | 31,215.19 | 501.76 |
| 减:营业外支出 | 167,363.24 | 669.16 | 1,285,729.22 | 988,595.81 |
| 五、利润总额 | 32,132,571.67 | 18,903,643.31 | 30,060,539.15 | 27,816,716.86 |
| 减:所得税费用 | 4,303,981 | 2,680,487.63 | 1,130,360.99 | 3,397,925.85 |
| 六、净利润 | 27,828,590.67 | 16,223,155.68 | 28,930,178.16 | 24,418,791.01 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 27,828,590.67 | 16,223,155.68 | 28,930,178.16 | 24,418,791.01 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 26,831,108.48 | 16,144,287.21 | 28,999,286.59 | 24,128,318.5 |
| 少数股东损益 | 997,482.19 | 78,868.47 | -69,108.43 | 290,472.51 |
| 扣除非经常损益后的净利润 | 6,890,181.99 | 4,808,487.99 | 11,877,067.05 | 12,561,156.24 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.05 | 0.09 | 0.07 |
| (二)稀释每股收益 | 0.08 | 0.05 | 0.09 | 0.07 |
| 九、综合收益总额 | 27,828,590.67 | 16,223,155.68 | 28,930,178.16 | 24,418,791.01 |
| 归属于母公司股东的综合收益总额 | 26,831,108.48 | 16,144,287.21 | 28,999,286.59 | 24,128,318.5 |
| 归属于少数股东的综合收益总额 | 997,482.19 | 78,868.47 | -69,108.43 | 290,472.51 |
| 公告日期 | 2026-08-25 | 2026-04-25 | 2026-04-17 | 2025-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |